{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:21:54Z","timestamp":1781576514462,"version":"3.54.5"},"reference-count":31,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>Infection represents the most common serious complication of shunt surgery, and typically its incidence ranges between 5 and 15%, despite the use of systemic antibiotic agents. Because systemic antibiotic medications generally penetrate the cerebrospinal fluid (CSF) poorly, the authors investigated, in a controlled study, whether the addition of intraventricular antibiotic treatment decreases the incidence of perioperative infection in adult patients.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Data pertaining to all CSF shunt procedures conducted at the authors\u2019 institution during an 11-year period were reviewed. Perioperative infection was defined as culture-positive CSF and the clinical presence of infection-related symptoms occurring within 90 days of surgery. All patients underwent intraoperative systemic antistaphylococcal antibiotic therapy. Before May 16, 1999, the senior author (R.H.S.) also administered 4 mg of gentamicin intraventricularly at surgery (Group I); thereafter, 10 mg of vancomycin was additionally administered (Group II). Other neurosurgeons at this institution did not use intraventricular antibiotic therapy, and their patients served as additional controls in identical time periods (Groups III and IV).<\/jats:p>\n<jats:p>A total of 802 shunt procedures were performed in 534 patients. Control infection rates were 5.4% (eight of 147) in Group I; 6.2% (nine of 145) in Group III; and 6.7% (18 of 267) in Group IV. With the combination of systemic antibiotic and intraventricular gentamicin and vancomycin (Group II), the infection rate fell significantly to 0.4% (one of 243). No complications were noted in association with intraventricular antibiotic administration.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The combination of intraventricular gentamicin and vancomycin with systemic antibiotic therapy significantly decreased the incidence of perioperative shunt infection. It is presumed that intraventricular antibiotic therapy extends prophylactic antibiotic coverage into the CSF and prevents bacterial seeding.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns.2006.105.2.242","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:37:17Z","timestamp":1201178237000},"page":"242-247","source":"Crossref","is-referenced-by-count":92,"title":["Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents"],"prefix":"10.3171","volume":"105","author":[{"given":"Brian T.","family":"Ragel","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Utah Health Sciences Center, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Browd","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah Health Sciences Center, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah Health Sciences Center, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-1050242","series-title":"Attributes to Guide the Development of Practice Parameters","year":"1990"},{"key":"b2-1050242","series-title":"J Neurotrauma","first-page":"641","article-title":"Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care","volume":"13","year":"1996"},{"key":"b3-1050242","series-title":"Childs Nerv Syst","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00381-004-1052-x","article-title":"Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children","volume":"21","year":"2005"},{"issue":"Suppl 1","key":"b4-1050242","series-title":"Z Kinderchir","first-page":"5","article-title":"A prospective randomised controlled trial of antimicrobial prophylaxis in hydrocephalus shunt surgery","volume":"45","year":"1990"},{"key":"b5-1050242","series-title":"Epilepsia","first-page":"92","article-title":"Implantation of a vagus nerve stimulator for refractory partial seizures: surgical outcomes of 454 study patients","volume":"39","year":"1998"},{"key":"b6-1050242","series-title":"Surgery","first-page":"161","article-title":"The effective period of preventive antibiotic action in experimental incisions and dermal lesions","volume":"50","year":"1961"},{"key":"b7-1050242","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/00006123-199808000-00068","article-title":"Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus","volume":"43","year":"1998"},{"key":"b8-1050242","series-title":"Clin Pharm","first-page":"866","article-title":"Treatment and prevention of infections of cerebrospinal fluid shunts","volume":"6","year":"1987"},{"key":"b9-1050242","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jac\/21.2.262-a","article-title":"Monitoring vancomycin concentrations in CSF after intraventricular administration","volume":"21","year":"1988"},{"key":"b10-1050242","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3171\/jns.2003.99.5.0831","article-title":"Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus","volume":"99","year":"2003"},{"key":"b11-1050242","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF01420065","article-title":"In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections","volume":"133","year":"1995"},{"key":"b12-1050242","series-title":"Infection","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s15010-002-2113-2","article-title":"Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections","volume":"31","year":"2003"},{"key":"b13-1050242","series-title":"J Infect Dis","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/infdis\/143.2.148","article-title":"Central nervous system toxicity of intraventricularly administered gentamicin in adult rabbits","volume":"143","year":"1981"},{"key":"b14-1050242","series-title":"Scand J Infect Dis","first-page":"57","article-title":"Intraventricular treatment of Serratia marcescens meningitis with gentamicin. Pharmacokinetic studies of gentamicin concentration in one case","volume":"8","year":"1976"},{"key":"b15-1050242","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/clinids\/17.1.98","article-title":"Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis","volume":"17","year":"1993"},{"key":"b16-1050242","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0090-3019(90)90238-K","article-title":"Vancomycin pharmacokinetics in hydrocephalic shunt prophylaxis and relationship to ventricular volume","volume":"34","year":"1990"},{"key":"b17-1050242","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmaco-dynamics in cerebrospinal fluid","volume":"27","year":"1998"},{"key":"b18-1050242","series-title":"Yale J Biol Med","first-page":"31","article-title":"Treatment of Gram-negative bacillary meningitis with intrathecal gentamicin","volume":"50","year":"1977"},{"key":"b19-1050242","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1128\/AAC.43.8.1932","article-title":"Bactericidal activity of vancomycin in cerebrospinal fluid","volume":"43","year":"1999"},{"key":"b20-1050242","series-title":"Ann Otol Rhinol Laryngol","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/000348948109000312","article-title":"Ototoxicity of intracisternal gentamicin in cats","volume":"90","year":"1981"},{"key":"b21-1050242","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1227\/01.NEU.0000146206.40375.41","article-title":"Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment","volume":"56","year":"2005"},{"key":"b22-1050242","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1473-3099(05)70084-0","article-title":"Infection in breast implants","volume":"5","year":"2005"},{"key":"b23-1050242","series-title":"Biomaterials","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/0142-9612(94)90080-9","article-title":"In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection","volume":"15","year":"1994"},{"key":"b24-1050242","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3171\/jns.2003.99.3.0500","article-title":"Complications of chronic vagus nerve stimulation for epilepsy in children","volume":"99","year":"2003"},{"key":"b25-1050242","series-title":"Schmidek & Sweet Operative Neurosurgical Technique. Indications, Methods, and Results","first-page":"1601","article-title":"Surgical treatment of the dyskinesias","volume":"Vol 1","year":"2000"},{"key":"b26-1050242","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ana.410040618","article-title":"Neurotoxicity of intrathecal gentamicin: a case report and experimental study","volume":"4","year":"1978"},{"key":"b27-1050242","series-title":"Neurosurg Clin N Am","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1042-3680(18)30666-1","article-title":"Infections in neurologic surgery. The intraventricular use of antibiotics","volume":"3","year":"1992"},{"key":"b28-1050242","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000050422","article-title":"The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons","volume":"35","year":"2001"},{"key":"b29-1050242","series-title":"Audiol Neurootol","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000058305","article-title":"Recent advances in understanding aminoglycoside ototoxicity and its prevention","volume":"7","year":"2002"},{"key":"b30-1050242","series-title":"Arch Dis Child","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/adc.51.9.686","article-title":"Intrathecal antibiotic therapy for neonatal meningitis","volume":"51","year":"1976"},{"key":"b31-1050242","series-title":"Pediatr Infect Dis J","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00006454-198702000-00015","article-title":"Failure of single-dose intraventricular vancomycin for cerebrospinal fluid shunt surgery prophylaxis","volume":"6","year":"1987"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/105\/2\/article-p242.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/105\/2\/article-p242.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/105\/2\/article-p242.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:46:15Z","timestamp":1709977575000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/105\/2\/article-p242.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":31,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/jns.2006.105.2.242","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}